Company
prazertx.com
Making Undruggable Targets Druggable,
Also known as Prazer Therapeutics
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Our Mission is to provide novel therapeutic strategies for patients suffering with refractory diseases.
Funding snapshot
- Latest round
- Undisclosed2026-08-05
Funding rounds
- Pre-IPO
- 2026-08-05
- Series B
- 2025-04-01
Loading relationship preview